Therapeutic Management of De Novo Urological Malignancy in Renal Transplant Recipients: The Experience of the French Department of Urology and Kidney Transplantation from Bordeaux

Urology

Volumn 75, Issue 1, 2010, Pages 126-132

  Elkentaoui, Hicham ^a   Robert, Grégoire ^a,b   Pasticier, Gilles ^a   Bernhard, Jean Christophe ^a   Couzi, Lionel ^a   Merville, Pierre ^a,b   Ravaud, Alain ^b,c   Ballanger, Philippe ^a,b   Ferrière, Jean Marie ^a,b   Wallerand, Hervé ^a,b  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BCG VACCINE; CYCLOSPORIN; MITOMYCIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CARCINOMA; KIDNEY GRAFT; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPHRECTOMY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINARY TRACT CANCER;

AGED; FEMALE; FRANCE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; UROLOGIC NEOPLASMS;

EID: 72249097715     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.06.106     Document Type: Article

References (30)

1. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl (1998) 147-158
2. Buzzeo B.D., Heisey D.M., and Messing E.M. Bladder cancer in renal transplant recipients. Urology 50 4 (1997) 525-528
3. Morath C., Mueller M., Goldschmidt H., et al. Malignancy in renal transplantation. J Am Soc Nephrol 15 (2004) 1582-1588
4. Ramsay H.M., Fryer A.A., Reece S., et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 36 1 (2000) 167-176
5. Zhou M., Zhu Y., Wang L., et al. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases. Clin Transpl (2006) 395-398
6. Lutz J., and Heemann U. Tumours after kidney transplantation. Curr Opin Urol 13 2 (2003) 105-109
7. Shum C.F., Lau K.O., Sy J.L., et al. Urological complications in renal transplantation. Singapore Med J 47 5 (2006) 388-391
8. Doublet J.D., Peraldi M.N., Gattegno B., et al. Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol 158 1 (1997) 42-44
9. Denton M.D., Magee C.C., Ovuworie C., et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int 61 6 (2002) 2201-2209
10. Tosaka A., Ohya K., Yamada K., et al. Incidence and properties of renal masses and asymptomatic renal cell carcinoma detected by abdominal ultrasonography. J Urol 144 5 (1990) 1097-1099
11. Hoshida Y., Nakanishi H., Shin M., et al. Renal neoplasias in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutations. Transplantation 68 3 (1999) 385-390
12. Konety B.R., Tewari A., Howard R.J., et al. Prostate cancer in the post-transplant population. Urologic Society for Transplantation and Vascular Surgery. Urology 52 3 (1998) 428-432
13. Cormier L., Lechevallier E., Barrou B., et al. Diagnosis and treatment of prostate cancers in renal-transplant recipients. Transplantation 75 2 (2003) 237-239
14. Kleinclauss F., Gigante M., Neuzillet Y., et al. Prostate cancer in renal transplant recipients. Nephrol Dial Transplant 23 7 (2008) 2374-2380
15. Kleinclauss F.M., Neuzillet Y., Tillou X., et al. Morbidity of retropubic radical prostatectomy for prostate cancer in renal transplant recipients: multicenter study from Renal Transplantation Committee of French Urological Association. Urology 72 6 (2008) 1366-1370
16. Master V.A., Meng M.V., Grossfeld G.D., et al. Treatment and outcome of invasive bladder cancer in patients after renal transplantation. J Urol 171 3 (2004) 1085-1088
17. Gifford R.R., Wofford J.E., and Edwards Jr. W.G. Carcinoma of the bladder in renal transplant patients. A case report and collective review of cases. Clin Transpl 12 1 (1998) 65-69
18. Besarani D., and Cranston D. Urological malignancy after renal transplantation. BJU Int 100 3 (2007) 502-505
19. Wu M.J., Lian J.D., Yang C.R., et al. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis 43 6 (2004) 1091-1097
20. Nortier J.L., Martinez M.C., Schmeiser H.H., et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342 23 (2000) 1686-1692
21. Li X.B., Xing N.Z., Wang Y., et al. Transitional cell carcinoma in renal transplant recipients: a single center experience. Int J Urol 15 1 (2008) 53-57
22. Swindle P., Falk M., Rigby R., et al. Transitional cell carcinoma in renal transplant recipients: the influence of compound analgesics. Br J Urol 81 2 (1998) 229-233
23. Neuzillet Y., Cabaniols L., Karam G., et al. Study of urothelial bladder tumours in renal transplant recipients. Prog Urol 16 3 (2006) 343-346
24. Sylvester R.J., Oosterlinck W., and van der Meijden A.P. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171 6 Pt. 1 (2004) 2186-2190
25. Deresiewicz R.L., Stone R.M., and Aster J.C. Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guerin. J Urol 144 6 (1990) 1331-1333
26. Palou J., Angerri O., Segarra J., et al. Intravesical bacillus Calmette-Guerin for the treatment of superficial bladder cancer in renal transplant patients. Transplantation 76 10 (2003) 1514-1516
27. Rischmann P., Desgrandchamps F., Malavaud B., et al. BCG intravesical instillations: recommendations for side-effects management. Eur Urol 37 suppl 1 (2000) 33-36
28. Hojo M., Morimoto T., Maluccio M., et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397 6719 (1999) 530-534
29. Tremblay F., Fernandes M., Habbab F., et al. Malignancy after renal transplantation: incidence and role of type of immunosuppression. Ann Surg Oncol 9 8 (2002) 785-788
30. Kälble T., Lucan M., Nicita G., et al. Guidelines on renal transplantation. Eur Urol 47 2 (2005) 156-166